國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Human iPS cells in disease modelling

Fukuda, Keiichi.

Human iPS cells in disease modelling

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Human iPS cells in disease modellingedited by Keiichi Fukuda.
其他作者:	Fukuda, Keiichi.
出版者:	Tokyo :Springer Japan :2016.
面頁冊數:	vii, 99 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Stem cells.
電子資源:	http://dx.doi.org/10.1007/978-4-431-55966-5
ISBN:	9784431559665$q(electronic bk.)

Human iPS cells in disease modelling
Human iPS cells in disease modelling[electronic resource] /edited by Keiichi Fukuda. - Tokyo :Springer Japan :2016. - vii, 99 p. :ill., digital ;24 cm.

Chapter 1 Recent Improvements and Emerging Issues in iPSC Generation for the Modeling of Disease -- Chapter 2 Cardiomyopathy -- Chapter 3 Modelling Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy with Patient-specific iPSCs -- Chapter 4 Cardiac Arrhythmia Modelling Using iPS Cells -- Chapter 5 iPSC Disease Modeling of Laminopathies -- Chapter 6 Hematological Disorders -- Chapter 7 Inherited Metabolic Disorders of the Liver.

Human iPS cells have a great potential to be cell sources for regenerative medicine because of the promise of infinite self-renewal and the capability to differentiate into multiple cell types. This book focuses on another great potential of human iPS cells, which is the establishment of human disease models using patient-specific iPS cells. Human iPS cells can be easily obtained from a patient's somatic cells and provide the entire information on the patient's genome. Accordingly, we can generate disease models for inheritable diseases in cell culture dishes using iPS cells. This is a quite new technique but holds tremendous potential for our increased understanding of pathogenesis, and will then be the basis for novel drug development industries. All the authors are leading researchers in this field and they have reported many kinds of patient-derived iPS cells. In this book, they introduce the aspects that could be recapitulated in terms of disease modelling as well as further innovative findings such as novel pathogenetic insights and novel therapies.

ISBN: 9784431559665$q(electronic bk.)

Standard No.: 10.1007/978-4-431-55966-5doiSubjects--Topical Terms:

200260
Stem cells.

LC Class. No.: QH588.S83

Dewey Class. No.: 616.02774

Human iPS cells in disease modelling
LDR:02476nmm a2200325 a 4500 001 483736
003 DE-He213
005 20160909110254.0
006 m d
007 cr nn 008maaau
008 161012s2016 ja s 0 eng d
020 $a 9784431559665$q(electronic bk.)
020 $a 9784431559641$q(paper)
024 7 $a 10.1007/978-4-431-55966-5 $2 doi
035 $a 978-4-431-55966-5
040 $a GP $c GP
041 0 $a eng
050 4 $a QH588.S83
072 7 $a PSAK $2 bicssc
072 7 $a SCI017000 $2 bisacsh
072 7 $a SCI049000 $2 bisacsh
082 0 4 $a 616.02774 $2 23
090 $a QH588.S83 $b H918 2016
245 0 0 $a Human iPS cells in disease modelling $h [electronic resource] / $c edited by Keiichi Fukuda.
260 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a vii, 99 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1 Recent Improvements and Emerging Issues in iPSC Generation for the Modeling of Disease -- Chapter 2 Cardiomyopathy -- Chapter 3 Modelling Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy with Patient-specific iPSCs -- Chapter 4 Cardiac Arrhythmia Modelling Using iPS Cells -- Chapter 5 iPSC Disease Modeling of Laminopathies -- Chapter 6 Hematological Disorders -- Chapter 7 Inherited Metabolic Disorders of the Liver.
520 $a Human iPS cells have a great potential to be cell sources for regenerative medicine because of the promise of infinite self-renewal and the capability to differentiate into multiple cell types. This book focuses on another great potential of human iPS cells, which is the establishment of human disease models using patient-specific iPS cells. Human iPS cells can be easily obtained from a patient's somatic cells and provide the entire information on the patient's genome. Accordingly, we can generate disease models for inheritable diseases in cell culture dishes using iPS cells. This is a quite new technique but holds tremendous potential for our increased understanding of pathogenesis, and will then be the basis for novel drug development industries. All the authors are leading researchers in this field and they have reported many kinds of patient-derived iPS cells. In this book, they introduce the aspects that could be recapitulated in terms of disease modelling as well as further innovative findings such as novel pathogenetic insights and novel therapies.
650 0 $a Stem cells. $3 200260
650 0 $a Cell culture. $3 197351
650 1 4 $a Life Sciences. $3 273679
650 2 4 $a Stem Cells. $3 203924
650 2 4 $a Cell Culture. $3 337771
700 1 $a Fukuda, Keiichi. $3 697062
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55966-5
950 $a Biomedical and Life Sciences (Springer-11642)